LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer
Recruiting · NCT05939063 · Interventional (participants receive a specific treatment) · Lead sponsor: Fudan University
View the official record on ClinicalTrials.gov →Interventions studied
LDPLRAMPS
What this trial is about
This multicenter randomized controlled clinical trial proposed the criteria for selecting patients with early-stage left-sided pancreatic cancer and aimed to compare the perioperative and oncological outcomes of patients within the criteria who underwent laparoscopic radical antegrade modular pancreatosplenectomy versus laparoscopic distal pancreatosplenectomy.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Clinically diagnosed as resectable left-sided pancreatic cancer before surgery.
- Imaging tumor diameter ≤ 4 cm.
- Located ≥ 1cm from the celiac trunk.
- Tumor didn't invade the fascial layer behind the pancreas.
- Be able to comply with research protocol.
- Voluntary participation and signed informed consent.
Exclusion criteria
- Received neoadjuvant therapy.
- Presence of liver or other distant metastasis.
- Multifocal or recurrent disease.
- History of other malignancies.
- Simultaneously participating in other clinical trials.
Where it is running
1 location listed.
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center - Shanghai, Shanghai Municipality, China